Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 10, 2025International Healthcare Review (online)Open Access

Continuous monitoring of cardiac function, use of beta-blockers and ACE inhibitors, and modifying cancer therapies are effective in mitigating cardiotoxicity.

View Full Paper
Ask AI
Bookmark
Share

Why the study?

Cardiotoxicity from chemotherapy and radiotherapy can lead to ventricular dysfunction and other cardiac complications, negatively impacting quality of life and cancer treatment effectiveness.

What are the effective clinical management strategies for the prevention and treatment of cardiotoxicity in cancer patients?

Design

Literature review

Authors

GEGabriela Bianchini EstevesDSDanielle Fernanda Schulze

Discussion

Loading...

Member takes

Overview

Highlights potential preventive strategies; leaves open need for prospective trials before practice change.

Structured PICO

What are the effective clinical management strategies for the prevention and treatment of cardiotoxicity in cancer patients?

P
Population
Cancer patients receiving treatments such as chemotherapy and radiotherapy
I
Intervention
Prevention and treatment methods including cardiac monitoring, cardioprotective medications (beta-blockers, ACE inhibitors), and adjustments in cancer therapies
O
Outcome
Prevention and treatment of cardiotoxicity, clinical outcomes, and quality of life

This review highlights the importance of continuous cardiac monitoring, cardioprotective medications, and multidisciplinary collaboration to prevent and treat cardiotoxicity in cancer patients.

Cite This Study

Esteves et al. (2025) studied this question.

synapsesocial.com/papers/6a84053fac510c864ff2ef55https://doi.org/10.56226/102
View Full Paper
Ask AI
Bookmark
Share